204 related articles for article (PubMed ID: 15461640)
1. Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
Milligan DW; Wheatley K; Burnett AK
Br J Haematol; 2004 Oct; 127(2):238-9. PubMed ID: 15461640
[No Abstract] [Full Text] [Related]
2. Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
Virchis A; Koh M; Rankin P; Mehta A; Potter M; Hoffbrand AV; Prentice HG
Br J Haematol; 2004 Jan; 124(1):26-32. PubMed ID: 14675405
[TBL] [Abstract][Full Text] [Related]
3. Treatment of myelodysplastic syndromes with AML-type chemotherapy.
Estey E; Pierce S; Kantarjian H; O'Brien S; Beran M; Andreeff M; Escudier S; Koller C; Kornblau S; Robertson L
Leuk Lymphoma; 1993; 11 Suppl 2():59-63. PubMed ID: 7510196
[No Abstract] [Full Text] [Related]
4. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E
Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
Kantarjian H; Beran M; Cortes J; O'Brien S; Giles F; Pierce S; Shan J; Plunkett W; Keating M; Estey E
Cancer; 2006 Mar; 106(5):1099-109. PubMed ID: 16435387
[TBL] [Abstract][Full Text] [Related]
6. FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.
de la Rubia J; Regadera A; Martín G; Cervera J; Sanz G; Martínez J; Jarque I; García I; Andreu R; Moscardó F; Jiménez C; Mollá S; Benlloch L; Sanz M
Leuk Res; 2002 Aug; 26(8):725-30. PubMed ID: 12191567
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
8. [An elderly patient with myelodysplastic syndrome successfully treated with combination of granulocyte-colony stimulating factor and continuous-drip infusion of low-dose cytarabine and etoposide].
Yamada T; Tsurumi H; Hara T; Fukuno K; Goto H; Oyama M; Moriwaki H
Rinsho Ketsueki; 2000 Mar; 41(3):218-21. PubMed ID: 10774251
[TBL] [Abstract][Full Text] [Related]
9. Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Keating MJ; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich EJ
Leukemia; 1992; 6 Suppl 2():78-80. PubMed ID: 1578950
[No Abstract] [Full Text] [Related]
10. High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
Beran M; Shen Y; Kantarjian H; O'Brien S; Koller CA; Giles FJ; Cortes J; Thomas DA; Faderl S; Despa S; Estey EH
Cancer; 2001 Oct; 92(8):1999-2015. PubMed ID: 11596013
[TBL] [Abstract][Full Text] [Related]
11. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
12. FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children.
Sarper N; Yalman N
Med Pediatr Oncol; 2000 Feb; 34(2):163. PubMed ID: 10657885
[No Abstract] [Full Text] [Related]
13. Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia.
Zhang X; Guo X
Ann Hematol; 2019 Sep; 98(9):2223-2225. PubMed ID: 30980106
[No Abstract] [Full Text] [Related]
14. Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Stramigioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G
Eur J Haematol; 2005 Apr; 74(4):277-81. PubMed ID: 15777338
[TBL] [Abstract][Full Text] [Related]
15. Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Salvucci M; Zanchini R; Molinari A; Zuffa E; Poletti V; Poletti G; Zaccaria A
Haematologica; 2000 Jul; 85(7):769-70. PubMed ID: 10897135
[No Abstract] [Full Text] [Related]
16. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V
Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203
[TBL] [Abstract][Full Text] [Related]
17. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.
Tomonari A; Takahashi S; Ooi J; Nakaoka T; Takasugi K; Uchiyama M; Tsukada N; Konuma T; Iseki T; Tojo A; Asano S
Eur J Haematol; 2006 Jul; 77(1):46-50. PubMed ID: 16573743
[TBL] [Abstract][Full Text] [Related]
18. The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
Hubeek I; Litvinova E; Peters GJ; Broekhuizen R; Haarman EG; Huismans DR; Cloos J; Zwaan CM; Fleischhack G; Creutzig U; Kaspers GJ
Int J Oncol; 2004 Dec; 25(6):1823-9. PubMed ID: 15547723
[TBL] [Abstract][Full Text] [Related]
19. Incorporating new modalities into guidelines. Topotecan for myelodysplastic syndromes.
Estey EH
Oncology (Williston Park); 1998 Nov; 12(11A):81-6. PubMed ID: 10028504
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of leukaemia with granulocyte colony-stimulating factor in a patient with aleukaemic leukaemia.
Fata F; Myers P; Addeo J; Nawabi I
Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):111-2. PubMed ID: 9349378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
